Opthea Completes Successful Meetings with FDA and EMA for OPT-302 Phase 3 Clinical Program in Wet AMD

by NASDAQ Market News August 21, 2020

NASDAQ Market News
Click here to email author

Immunohistochemistry Market by Product, Application, End-user – Global Forecast to 2025

Tiziana Granted a Patent on the Use of Milciclib in Combination with Tyrosine Kinase Inhibitors for Treatment of Hepatocellular Carcinoma and other Cancers

Ads